Only 1 of 11 Canadian Medical Associations Covers GLP-1 Obesity Drugs, Despite Lower Costs
Canadian Medical Associations Largely Exclude GLP-1s for Obesity from Physician Insurance PlansMedicare update: Millions will see GLP-1 costs plummet to $50 per monthGLP-1 therapies for obesity: mechanisms, outcomes, and regulatory challenges - Academia.eduGLP-1 drugs are already known for fighting obesity, diabetes, heart disease, and kidney disease. Studies have even linked them to reduced cravings for alcohol and addictive substances. Now, new research suggests theyGLP-1 medications are everywhere right now, it's a convo on social media, in doctor's offices, you name it. That said, when a medication reduces appetite, changes weight quickly, and is praised as